Recaticimab Antibody
Recaticimab (SHR-1209) is a humanized anti-PCSK9 monoclonal antibody that lowers plasma LDL-C by stabilizing hepatic LDL receptors. It is a research candidate for hypercholesterolemia, with studies demonstrating its efficacy in both in vitro cellular assays and in vivo preclinical models of cardiovascular disease.
Product Specifications
Product Name Alternative
SHR1209, SHR-1209
Target
LDLR, Others
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Metabolism Research
Concentration
5.88 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
148.41 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
